This sparked the idea that GLP-1 analogs with enhanced stability could be developed as potential treatments for type 2 diabetes
For endometriosis, a condition frequently treated with progestins, this discovery opens a new theoretical possibility: GLP-1 medications might someday enhance response to hormonal therapy
REWIND, Researching Cardiovascular Events With a Weekly Incretin in Diabetes
"So it's very challenging," Yacawych says, "to be able to separate these side effects, like nausea, from GLP-1's intended effects, like weight loss." A possible workaround came from a team led by Ernie Blevins of the University of Washington
Mejoran el control glucmico y pueden ayudar en el manejo del peso
Because theyre losing 15% to 20% of their body weightwithout intense diets or workouts